awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33628778-5F621308-E974-48E0-AA1C-AEDC4A5B9DE3
Q33628778-5F621308-E974-48E0-AA1C-AEDC4A5B9DE3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33628778-5F621308-E974-48E0-AA1C-AEDC4A5B9DE3
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.
P2860
Q33628778-5F621308-E974-48E0-AA1C-AEDC4A5B9DE3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33628778-5F621308-E974-48E0-AA1C-AEDC4A5B9DE3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0575939eba712e7896a547847332ce2e524e905e
P2860
Impaired membrane transport in methotrexate-resistant CCRF-CEM cells involves early translation termination and increased turnover of a mutant reduced folate carrier.